Related Experiment Video
Updated: May 3, 2026

Quantitative Determination of De Novo Fatty Acid Synthesis in Brown Adipose Tissue Using Deuterium Oxide
Published on: May 12, 2023
Overactivation of intestinal SREBP2 in mice increases serum cholesterol
Ke Ma1, Pooja Malhotra1, Vinay Soni1
1Division of Gastroenterology and Hepatology, Department of Medicine, University of Illinois at Chicago, Chicago, Illinois, United States of America.
Abstract:
Sterol Response Element Binding Protein 2 (SREBP2) transcription factor is a master regulator of cholesterol homeostasis. Treatment with statins, inhibitors of cholesterol synthesis, activates intestinal SREBP2, which may hinder their cholesterol-lowering effects. Overactivation of SREBP2 in mouse liver was shown to have no effect on plasma cholesterol. However, the influence of activating intestinal SREBP2 on plasma cholesterol is not known. We have generated a novel transgenic mouse model with intestine specific overexpression of active SREBP2 (ISR2) driven by villin promoter. ISR2 mice showed overexpression of active SREBP2 specifically in the intestine. Microarray analysis of jejunal RNA from ISR2 mice showed a significant increase in genes involved in fatty acid and cholesterol synthesis. Cholesterol and triglyceride (TG) in jejunum and liver (mg/g protein) were significantly increased in ISR2 vs wild type mice. Serum Cholesterol was significantly increased in VLDL and LDL fractions whereas the level of serum triglycerides was decreased in ISR2 vs wild type mice. In conclusion, activation of intestinal SREBP2 alone seems to be sufficient to increase plasma cholesterol, highlighting the essential role of intestine in maintaining cholesterol homeostasis in the body.
Insights
Activating intestinal Sterol Response Element Binding Protein 2 (SREBP2) increases cholesterol levels. This highlights the intestine's crucial role in maintaining body cholesterol homeostasis.
Area of Science:
- Biochemistry
- Molecular Biology
- Genetics
Background:
- Sterol Response Element Binding Protein 2 (SREBP2) is a key regulator of cholesterol homeostasis.
- Statins activate intestinal SREBP2, potentially counteracting their cholesterol-lowering effects.
- The impact of intestinal SREBP2 activation on plasma cholesterol was previously unknown.
Purpose of the Study:
- To investigate the effect of intestine-specific overexpression of active SREBP2 on cholesterol metabolism.
- To determine if activating intestinal SREBP2 alone is sufficient to alter plasma cholesterol levels.
Main Methods:
- Generation of a novel transgenic mouse model (ISR2) with intestine-specific active SREBP2 overexpression using the villin promoter.
- Microarray analysis of jejunal RNA to assess gene expression changes.
- Quantification of cholesterol and triglyceride levels in jejunum, liver, and serum.
Main Results:
- ISR2 mice exhibited specific overexpression of active SREBP2 in the intestine.
- Increased expression of genes involved in fatty acid and cholesterol synthesis in the jejunum.
- Elevated cholesterol and triglyceride levels in the jejunum and liver of ISR2 mice compared to wild-type.
- Increased serum cholesterol in VLDL and LDL fractions, with decreased serum triglycerides in ISR2 mice.
Conclusions:
- Intestine-specific activation of SREBP2 is sufficient to raise plasma cholesterol levels.
- This study underscores the critical role of the intestine in maintaining overall body cholesterol homeostasis.
- Findings suggest potential therapeutic implications for managing cholesterol disorders.
Related Concept Videos
Cholesterol: Significance and Regulation
Considering cholesterol and...
Regulation of Nuclear Protein Sorting
Cell Specific Gene Expression

